This inventor holds 1 USPTO granted patent. Top assignee: Shenyang Research Institute of Chemical Industry. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Haihong Guang
Introduction
Haihong Guang is a prominent inventor based in Liaoning, China, recognized for his significant contribution to the field of chemical engineering and pharmaceuticals. With one patented invention under his name, Guang's work focuses on the development of therapeutic methods targeting specific enzymatic activities, marking him as a noteworthy figure in modern scientific innovation.
Latest Patents
Guang's most notable patent is related to a vinylarene derivative that plays a crucial role in modulating or inhibiting the enzymatic activity of indoleamine 2,3-dioxygenase 1 (IDO-1). This groundbreaking invention is expected to introduce new therapeutic methods and approaches for diseases associated with IDO enzymes. The patent outlines not only the compound itself but also its stereoisomers—cis and trans variants—as well as its pharmaceutically acceptable salts, showcasing the comprehensive nature of Guang's research.
Career Highlights
Currently, Haihong Guang is affiliated with the Shenyang Research Institute of Chemical Industry Co., Ltd., where his innovative research is grounded in the application of chemical compounds for therapeutic use. His efforts have contributed to advancing knowledge and technologies within the industry, demonstrating the potential for vinylarene derivatives in clinical applications.
Collaborations
Throughout his career, Guang has collaborated with notable colleagues including Zhaojin Ran and Baoshan Chai. These partnerships not only enhance the research quality but also foster an environment of shared knowledge and innovation, further driving the progress in their field.
Conclusion
Haihong Guang's contributions to the realm of chemical engineering and pharmaceuticals are marked by his innovative vinylarene derivative patent. His work holds promise for new medical therapies, and through collaborations with esteemed colleagues, he continues to make strides in the research community. The impact of his inventions could pave the way for significant advancements in the treatment of diseases associated with IDO-1 enzymes.